Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
MOMA Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Aarhus University Hospital
ARTBIO Inc.
Actuate Therapeutics Inc.
Hoffmann-La Roche
National Cancer Institute (NCI)
GlaxoSmithKline
Mayo Clinic
M.D. Anderson Cancer Center
University of Oklahoma
Werewolf Therapeutics, Inc.
M.D. Anderson Cancer Center
Martini-Klinik am UKE GmbH
Tyra Biosciences, Inc
University Health Network, Toronto
University of Wisconsin, Madison
H. Lee Moffitt Cancer Center and Research Institute
Shanghai Changzheng Hospital
M.D. Anderson Cancer Center
University of California, San Francisco
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Indiana University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
Sensei Biotherapeutics, Inc.
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Eli Lilly and Company
AstraZeneca
AstraZeneca
Carisma Therapeutics Inc
University Hospital, Ghent
Movember Foundation
Salubris Biotherapeutics Inc
Adaptimmune
National University Hospital, Singapore